Trials / Completed
CompletedNCT00444782
A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
"Heptovax" - A Phase II, Open-Label Trial Evaluating the Safety and Efficacy of GV1001 in Advanced Hepatocellular Carcinoma.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 41 (estimated)
- Sponsor
- Pharmexa A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy of GV1001 in locally advanced or metastatic HCC. Also the safety of GV1001 and immunogenicity will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | GV1001 |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-03-08
- Last updated
- 2008-12-18
Locations
3 sites across 3 countries: France, Germany, Spain
Source: ClinicalTrials.gov record NCT00444782. Inclusion in this directory is not an endorsement.